These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817 [TBL] [Abstract][Full Text] [Related]
26. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269 [TBL] [Abstract][Full Text] [Related]
27. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. Sullivan PA; Kelleher M; Twomey M; Dineen M J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484 [TBL] [Abstract][Full Text] [Related]
28. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
29. Pituitary - adrenocortical function in patients during treatment with the angiotensin-converting enzyme inhibitor captopril. Angeli A; Bisbocci D; Orlandi F; Paccotti P; Tabasso R; Tamagnone C; Lavezzaro GC Clin Endocrinol (Oxf); 1981 Dec; 15(6):555-65. PubMed ID: 6276052 [TBL] [Abstract][Full Text] [Related]
30. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
31. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme. Weber MA; Drayer JI; Priest RT; Chen TC Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161 [TBL] [Abstract][Full Text] [Related]
32. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Ideishi M; Sasaguri M; Ikeda M; Arakawa K Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133 [TBL] [Abstract][Full Text] [Related]
33. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position. Morganti A; Pickering TG; Lopez-Ovejero J; Laragh JH Clin Sci (Lond); 1979 Dec; 57 Suppl 5():149s-152s. PubMed ID: 232018 [No Abstract] [Full Text] [Related]
34. [Evaluation of the acute effect of a converting enzyme inhibitor, captopril, in normal and hypertensive subjects]. Mimran A; Laroche B; Targhetta R; Roumieux JL Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():61-5. PubMed ID: 6794529 [TBL] [Abstract][Full Text] [Related]
35. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension. Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685 [TBL] [Abstract][Full Text] [Related]
36. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225). Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048 [TBL] [Abstract][Full Text] [Related]
37. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347 [TBL] [Abstract][Full Text] [Related]
38. Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225). Izumi Y; Honda M; Hatano M; Kawahara Y Tohoku J Exp Med; 1983 Mar; 139(3):279-86. PubMed ID: 6304936 [TBL] [Abstract][Full Text] [Related]
39. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)]. Overlack A; Stumpe KO; Heck I; Krück F Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920 [TBL] [Abstract][Full Text] [Related]
40. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system]. Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]